Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

44.33
+4.1510.33%
Post-market: 44.20-0.1300-0.29%19:59 EDT
Volume:1.97M
Turnover:83.91M
Market Cap:843.09M
PE:-4.66
High:44.33
Open:40.71
Low:39.10
Close:40.18
52wk High:44.33
52wk Low:6.48
Shares:19.02M
Float Shares:16.64M
Volume Ratio:1.52
T/O Rate:11.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.5163
EPS(LYR):-8.6765
ROE:-440.80%
ROA:-31.57%
PB:-34.82
PE(LYR):-5.11

Loading ...

Sep 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 24, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities